本周热点恒瑞一季报:营收净利双增超20%4月25日,恒瑞医药发布2025年第一季度财报:实现营业收入72.06亿元,同比增长20.14%,归属于上市公司股东的净利润18.74亿元,同比增长36.90%,归属于上市公司股东的扣非净利润18.63亿元,同比增长29.35%。对于净利润的增长,恒瑞在报告中表示,主要原因是收到IDEAYA 7500万美元的对外许可首付款,确认为收入,利润增加较多。2024...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.